ES2433248B1 - Copolimeros anfifilicos portadores de alfa-tocoferol con propiedades antitumorales - Google Patents

Copolimeros anfifilicos portadores de alfa-tocoferol con propiedades antitumorales Download PDF

Info

Publication number
ES2433248B1
ES2433248B1 ES201230679A ES201230679A ES2433248B1 ES 2433248 B1 ES2433248 B1 ES 2433248B1 ES 201230679 A ES201230679 A ES 201230679A ES 201230679 A ES201230679 A ES 201230679A ES 2433248 B1 ES2433248 B1 ES 2433248B1
Authority
ES
Spain
Prior art keywords
amphifilic
tocoferol
alfa
copolymers
carrying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201230679A
Other languages
English (en)
Other versions
ES2433248A1 (es
Inventor
Suay Raquel Palao
Ruiz Francisco Jesus Parra
De Armas Maria Rosa Aguilar
Gutierrez Mar Fernandez
Caceres Juan Parra
Roman Del Barrio Julio San
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina CIBERBBN
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina CIBERBBN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina CIBERBBN filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to ES201230679A priority Critical patent/ES2433248B1/es
Priority to PCT/ES2013/070287 priority patent/WO2013167782A1/es
Publication of ES2433248A1 publication Critical patent/ES2433248A1/es
Application granted granted Critical
Publication of ES2433248B1 publication Critical patent/ES2433248B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
    • C08F220/30—Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety
    • C08F220/302—Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety and two or more oxygen atoms in the alcohol moiety
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F226/06—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a heterocyclic ring containing nitrogen
    • C08F226/10—N-Vinyl-pyrrolidone
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES201230679A 2012-05-07 2012-05-07 Copolimeros anfifilicos portadores de alfa-tocoferol con propiedades antitumorales Expired - Fee Related ES2433248B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201230679A ES2433248B1 (es) 2012-05-07 2012-05-07 Copolimeros anfifilicos portadores de alfa-tocoferol con propiedades antitumorales
PCT/ES2013/070287 WO2013167782A1 (es) 2012-05-07 2013-05-07 Copolímeros anfifílicos portadores de alfa-tocoferol con propiedades antitumorales

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201230679A ES2433248B1 (es) 2012-05-07 2012-05-07 Copolimeros anfifilicos portadores de alfa-tocoferol con propiedades antitumorales

Publications (2)

Publication Number Publication Date
ES2433248A1 ES2433248A1 (es) 2013-12-10
ES2433248B1 true ES2433248B1 (es) 2015-03-10

Family

ID=49550189

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201230679A Expired - Fee Related ES2433248B1 (es) 2012-05-07 2012-05-07 Copolimeros anfifilicos portadores de alfa-tocoferol con propiedades antitumorales

Country Status (2)

Country Link
ES (1) ES2433248B1 (es)
WO (1) WO2013167782A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108721636B (zh) * 2018-06-08 2021-03-02 陕西师范大学 联硒键连接的具有双重响应性的药物递送材料及其制备方法和应用
ES2735638B2 (es) * 2018-06-18 2021-01-18 Alodia Farm S L Copolimeros y terpolimeros acrilicos funcionales autoasociados y su uso como vehiculos de compuestos bioactivos
EP3884963A1 (en) * 2020-03-26 2021-09-29 Consejo Superior de Investigaciones Científicas (CSIC) Naproxen/dexamethasone-based nanoparticles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100195291B1 (ko) * 1997-07-12 1999-06-15 서경배 비이온성 비타민
US20080045559A1 (en) * 2003-10-29 2008-02-21 Sonus Pharmaceuticals, Inc. Tocopherol-modified therapeutic drug compounds
EP1742665B1 (en) * 2004-05-06 2011-11-02 Samyang Corporation Delivery system for bioactive agents on the basis of a polymeric drug carrier comprising an amphiphilic block polymer and a polylacticacid derivative
FR2952936B1 (fr) * 2009-11-26 2011-11-25 Flamel Tech Polymere de type acrylique ou methacrylique comprenant des greffons alpha-tocopherol

Also Published As

Publication number Publication date
WO2013167782A1 (es) 2013-11-14
ES2433248A1 (es) 2013-12-10

Similar Documents

Publication Publication Date Title
BR112015008232A2 (pt) conjugados pirrolbenzodiazepina-anticorpo
SG11201508109PA (en) Silane-containing carboxyl-terminated polymers
DK3293183T3 (da) Hæmmerforbindelser
BR112014028487A2 (pt) braçadeira
EP2933279A4 (en) COPOLYMER
DE112013004614T8 (de) Gestentastatur mit Gestenannullierung
GB201507863D0 (en) Variator
UA26261S (uk) Навушник
BR112014021748A2 (pt) conjunto de grampo
ES2855169T8 (es) Conjugados de polipéptido-anticuerpo derivados de aprotinina
TWI561543B (en) Multy-block copolymer
BR112014022506A2 (pt) variantes de cbh1a
GB201201357D0 (en) Poly oligosiloxysilane
DK2854928T3 (da) Multilumenkateter med forbedrede strømningsegenskaber
GB201201068D0 (en) Variator
GB201511298D0 (en) Golf-driving ranges
GB2514294B (en) Variator
ES2433248B1 (es) Copolimeros anfifilicos portadores de alfa-tocoferol con propiedades antitumorales
PL2900733T3 (pl) Kopolimery z grupami gem-acetofosfonowymi
GB201308738D0 (en) Novel polymer conjugates
FR2992527B3 (fr) Sous-vetement de securite
BR112015001715A2 (pt) dispositivo de tamponamento
FR2994990B1 (fr) Volet de desenfumage
ES1076984Y (es) Transportador de palots
ES1078100Y (es) Dispositivo de obturacion de conductos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2433248

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20150310

FD2A Announcement of lapse in spain

Effective date: 20210915